vancomycin has been researched along with curcumin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandi, SK; Kumar, P; Mukhopadhyay, K; Rawat, DS | 1 |
| Ahmida, MH | 1 |
| Mobarez, AM; Nikkhah, M; Sadaqat, MH | 1 |
| Feng, W; Kang, X; Li, G; Li, H; Liu, F; Wang, X; Zhao, D; Zheng, W | 1 |
| Akbari, J; Amoli, FA; Atyabi, F; Dinarvand, R; Ebrahimnejad, P; Javar, HA; Razavi, MS; Weppelmann, TA | 1 |
5 other study(ies) available for vancomycin and curcumin
| Article | Year |
|---|---|
Synthesis of novel monocarbonyl curcuminoids, evaluation of their efficacy against MRSA, including ex vivo infection model and their mechanistic studies.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Diarylheptanoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Viability | 2020 |
Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Free Radicals; Kidney Diseases; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vancomycin | 2012 |
Curcumin carbon dots inhibit biofilm formation and expression of esp and gelE genes of Enterococcusfaecium.
Topics: Anti-Bacterial Agents; Biofilms; Carbon; Curcumin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virulence Factors | 2022 |
Dual-targeted poly(amino acid) nanoparticles deliver drug combinations on-site: an intracellular synergistic strategy to eliminate intracellular bacteria.
Topics: Amino Acids; Anti-Bacterial Agents; Curcumin; Drug Combinations; Methicillin-Resistant Staphylococcus aureus; Nanoparticles; Vancomycin | 2023 |
Development of dual-functional core-shell electrospun mats with controlled release of anti-inflammatory and anti-bacterial agents for the treatment of corneal alkali burn injuries.
Topics: Alkalies; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Burns, Chemical; Curcumin; Delayed-Action Preparations; Drug Carriers; Eye Burns; Humans; Rabbits; Vancomycin | 2023 |